4,742 CompaniesAccess all companies
Spotfolio tracks over one million companies in technology industries.
There are 4,742 companies in the field of Biotechnology on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Patients, Disease, Therapeutic, Research, Treatment, Scientific, Unmet .
Early-stage companies (1,170)
Established companies (2,449)
The majority of these companies is located in the following countries.
United States (2,613)
United Kingdom (307)
Example CompaniesFind companies in your area
INFLUENZA X Unmet Medical Need Seasonal influenza still causes as many as 500,000 deaths every year. Influenza pandemics have killed millions of people ...
and the compounds are now ready to enter into pre-clinical studies. CMV X Unmet Medical Need Cytomegalovirus is a common virus which infects people of all ...
models for efficacy (where available) and in GLP toxicology studies. RSV X Unmet Medical Need Respiratory syncytial virus causes acute lower respiratory tract ...
models for efficacy (where available) and in GLP toxicology studies. HSV-2 X Unmet Medical Need Herpes Simplex Virus (HSV) is generally categorized into two ...
models for efficacy (where available) and in GLP toxicology studies. HIV X Unmet Medical Need HIV remains a great challenge for humanity even 4 decades after ...
Pipeline - The Team - Partnering We develop therapeutics for viral diseases of unmet medical need. About Us We are a bio-pharmaceutical company involved in
Ichorion Therapeutics Ichorion Therapeutics Inc.
Pipeline Targeting Conditions Where Current Treatments Fail to Address Unmet Medical Needs Our pipeline is built upon compelling science targeting Rare ...
Pipeline Market Need: Addressing Sizeable Patient Populations with Significant Unmet Need In Rare and Orphan Diseases Scientific Publications CERC-002 CERC-006
Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases. About About ...
Difference in the Lives of Patients Cerecor's pipeline of programs addresses unmet needs within Rare Pediatric and Orphan diseases. Our goal is to make life-changing
Home - Our Focus - News Empire Biotechnologies Treating Significant unmet medical needs Business Model Empire Biotechnologies is a therapeutics company ...
company developing best-in-class therapies for diseases with significant unmet medical needs. We incubate promising early-stage projects through strategic
Aclipse Therapeutics Aclipse Therapeutics LLC
developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining
that may include life threatening infections and tumors. Thus, there is an unmet clinical need for methods of targeted immune-regulation. Our proprietary ...
better treat diseases. Lead Programs Our lead programs address significant unmet needs in the fields of Type 1 Diabetes, Rheumatoid Arthritis, Inflammatory
Diseases MORE ABOUT OUR NOVEL TECHNOLOGY Our Vision Addressing significant unmet needs in the field of autoimmunity through the development of novel patented
TopicsSearch by any topic
Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.
The following topics addressed by the majority of companies help you discover major players in the field.
Use CasesRegister now
Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.
Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.